Neupogen (filgrastim, G-CSF) to treat diabetic foot infections
December 1997
Researchers are now trying Neupogen (filgrastim, G-CSF) to treat diabetic foot infections.
This is very preliminary...but initial results look promising.
Neupogen is usually given to increase the PRODUCTION of neutrophils. In this situation, it's used to improve their FUNCTION.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote